SMOC2 and neoplasm: In other cancers, decreased expression of these genes has been associated with vascular invasion and increased tumor aggressiveness [SLC5A5/NIS (58)], increased proliferation [SMOC2 (51)], increased migration [SMOC2 (51), CCBE1 (59, 60)], and poor prognosis [ECEL (61)].